$25.50+0.18 (+0.71%)
Acadia Healthcare Company, Inc.
Acadia Healthcare Company, Inc. in the Healthcare sector is trading at $25.50 with a market capitalization of $2.4B. Wall Street consensus targets $28.86 (14 analysts), implying a +13.2% move over the next 12 months. The stock is currently 16% below its 52-week high of $30.20, remaining 22.4% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilit...
Acadia Healthcare Company Inc. (NASDAQ:ACHC) is one of the 10 most promising mid-cap healthcare stocks according to hedge funds. On May 4, following a strong first-quarter report, Raymond James upgraded its rating on Acadia Healthcare Company, Inc. (NASDAQ:ACHC) from Outperform to Strong Buy. The firm also adjusted its price target upward from $25 to $39, […]
Mid-Day Stocks: Stocks are trading lower on Wednesday, as oil and yields move higher. Once again, it was “Welcome back, my friends to the show that never ends.” On cue, the never-say-die stock market shook off early worries and all the major indices closed higher on Tuesday. Like the proverbial broken record, the S&P 500 ... Here Are Wednesday’s Top Wall Street Analyst Research Calls: Boyd Gaming, Chipotle Mexican Grill, Conagra, Dollar General, MGM Resorts International, Omnicom Group, Yum! Bra
Yum! Brands upgraded, Chipotle downgraded: Wall Street's top analyst calls
Buckley Capital Advisors, an investment management company, released its first quarter 2026 investor letter. A copy of the letter can be downloaded here. The first quarter of 2026 presented some difficulties for small and mid-cap equities. However, the Fund observed a notable performance improvement in April, with the portfolio rising approximately 13.8% net month-to-date and […]
In the past quarter, Acadia Healthcare reported adjusted first-quarter earnings that exceeded estimates, supported by higher patient days, improved revenue per patient day, and 14% year-over-year revenue growth in its Acute Inpatient Psychiatric Facilities business. The company also issued second-quarter 2026 guidance of US$835 million–US$850 million in revenue and adjusted earnings per share of US$0.30–US$0.40, highlighting the growing contribution of its acute inpatient psychiatric...